| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| CYP17A1 |
beta-Alanine, N-((17-(5-fluoro-3-pyridinyl)estra-1,3,5(10),16-tetraen-3-yl)carbonyl)-N-methyl- |
NA |
200000 |
NA |
NA |
NA |
NA |
BindingDB |
| CYP17A1 |
[(3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] imidazole-1-carboxylate |
NA |
122000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| CYP17A1 |
(3S,8R,9S,10R,13S,14S)-17-indol-1-yl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol |
NA |
130000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| CYP17A1 |
[(3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] pyridine-4-carboxylate |
NA |
132000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| CYP17A1 |
N-[(8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-3-ylidene]hydroxylamine |
NA |
258000 |
NA |
NA |
NA |
NA |
TTD |
| CYP17A1 |
1-[(8R,9S,10R,13S,14S)-10,13-dimethyl-3-nitroso-2,3,6,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl]benzimidazole |
NA |
258000 |
NA |
NA |
NA |
NA |
BindingDB |
| CYP19A1 |
7-(benzyloxy)-3-phenyl-2-[(pyridin-4-ylmethyl)sulfanyl]-4H-chromen-4-one |
NA |
210000 |
NA |
NA |
NA |
NA |
BindingDB |
| CYP19A1 |
4-chloro-N-[3-({[(4-chlorophenyl)sulfonyl]amino}methyl)benzyl]benzenesulfonamide |
NA |
50003453 |
NA |
NA |
NA |
NA |
BindingDB |
| CYP19A1 |
4-methoxy-N-[3-[(4-methoxyphenyl)sulfonylamino]phenyl]benzenesulfonamide |
NA |
529663444|529663443.9 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| CYP19A1 |
3-(1a,2,3,7b-Tetrahydro-1H-cyclopropa[a]naphthalen-1-yl)-thiophene |
NA |
250000 |
NA |
NA |
NA |
NA |
TTD |
| CYP19A1 |
(2E)-2-[(2-amino-1,3-thiazol-5-yl)methylidene]-3,4-dihydronaphthalen-1-one |
NA |
250000 |
NA |
NA |
NA |
NA |
TTD |
| CYP19A1 |
2-(hydroxy-pyridazin-3-yl-methyl)-3,4-dihydro-2H-naphthalen-1-one |
NA |
250000 |
NA |
NA |
NA |
NA |
TTD |
| CYP19A1 |
2-(1a,2,3,7b-Tetrahydro-1H-cyclopropa[a]naphthalen-1-yl)-pyridine |
NA |
250000 |
NA |
NA |
NA |
NA |
TTD |
| CYP19A1 |
2-(hydroxy-pyridazin-4-yl-methyl)-3,4-dihydro-2H-naphthalen-1-one |
NA |
250000 |
NA |
NA |
NA |
NA |
TTD |
| CYP19A1 |
(2E)-2-(pyridazin-4-ylmethylidene)-3,4-dihydronaphthalen-1-one |
NA |
103000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| CYP19A1 |
2-(hydroxy-pyrazin-2-yl-methyl)-3,4-dihydro-2H-naphthalen-1-one |
NA |
250000 |
NA |
NA |
NA |
NA |
TTD |
| CYP19A1 |
8-(Imidazol-1-yl)-5,6,7,8-tetrahydroquinoline |
NA |
111000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| CYP19A1 |
(2E)-2-(pyridazin-3-ylmethylidene)-3,4-dihydronaphthalen-1-one |
NA |
250000 |
NA |
NA |
NA |
NA |
TTD |
| CYP19A1 |
Licoagrochalcone A |
NA |
308300 |
NA |
NA |
NA |
NA |
TTD |
| CYP19A1 |
(4S,8R,9S,10S,13S,14S)-10-(hydroxymethyl)-4-methoxy-13-methyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one |
NA |
150000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |